← Scoopfeeds — Intelligent news, curated.
Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD)
business

Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD)

Yahoo Finance · May 31, 2026, 10:55 AM · Also reported by 4 other sources

Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD)

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Goldman Sachs initiates Suja Life stock coverage with buy rating Investing.com Goldman Sachs initiates HawkEye 360 stock with buy rating Investing.com Goldman Sachs initiates Octave Intelligence stock at neutral Investing.com Jefferies initiates Suja Life stock coverage with buy rating

More in business

Decrypt
Strategy's Bitcoin Sale Timing Throws $50 Million Polymarket Bet Into Dispute
Investing.com
Dolphin entertainment CEO O’Dowd buys $4,867 in stock
Bloomberg Markets
The Copper Demand is Exceeding The Global Supply Says Groves
Investing.com
Form 144 Oklo Inc. For: 1 June
Investing.com
Form 8K PUREBASE CORPORATION For: 1 June
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop